co-presented by
ASSOCIATE SPONSORS
co-presented by
ASSOCIATE SPONSORS
Opto Circuits is working towards improving its footprint in the domestic market by participating in the Make in India initiative, says CMD Vinod Ramnani in an interview to CNBC-TV18.
Vinod Ramnani, Chairman and Managing Director, Opto Circuits, discusses about the company's future outlook.
Opto Circuits group company Cardiac Science has introduced automated external Defibrillator (AED) Powerheart G5 in US and Canadian markets, said Vinod Ramnani, CMD, Opto Circuits.
Investors bought more shares of Opto Circuits India on Wednesday after its subsidiary received approval from the USFDA for its Powerheart G5 AED with CRPD. The stock rallied 14 percent intraday.
Speaking about its fourth quarter numbers, Vinod Ramnani of Opto Circuits said it was below expectations and the company is taking steps to address working capital issues.
Shares of medical device manufacturer Opto Circuits (India) extended gains to 4.82 percent to Rs 110.80 on Thursday on the Bombay Stock Exchange after the board of directors approved issue of warrants to promoter.
Medical equipment maker Opto Circuits India gained 4 percent on Thursday ahead of board meeting today.
After an acquisition binge, Opto Circuits' Vinod Ramnani is looking to grow from within.
In an interview with CNBC-TV18, Vinod Ramnani, CMD of Opto Circuits said the company is not facing any stress on its liquidity position and its working capital cycle remains at 135-140 days. Moreover, the Opto Circuits' capex for the current year is Rs 250 crore, added Ramnani.
